FL-101

DRUG2 trials

Sponsors

Flame Biosciences

Conditions

Muscle Invasive Bladder CarcinomaNon-Small Cell Lung Cancer

Early Phase 1

FL- 101 Study in Non-Metastatic MIBC

WithdrawnNCT05395260

Flame BiosciencesMuscle Invasive Bladder Carcinoma

Start: 2022-08-22End: 2022-12-28Updated: 2022-08-19

Phase 2

FL-101 in Surgically Resectable Non-Small Cell Lung Cancer

WithdrawnNCT04758949

Flame BiosciencesNon-Small Cell Lung Cancer

Start: 2021-08-25End: 2021-12-22Updated: 2022-01-11